Clinical Trial Update: A Study of LY3532226 in Participants With Obesity [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of LY3532226 for obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LY3532226

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 1 | Status: COMPLETED